Paul M. Spring
Associate Professor and Director of Research
Formerly Arkansas Affiliated with UA Little Rock, UAMS through 2011.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Paul M. Spring's research focuses on cancer treatment, particularly head and neck squamous cell carcinoma. His work investigates methods to enhance the efficacy of chemotherapy and radiation, including the potentiation of Paclitaxel by low-dose fractionated radiation in tumor cell lines with varying p53 status. He has also explored the mechanisms of drug resistance in head and neck cancers, examining the role of microRNA expression profiles and increased mitochondrial DNA. Additionally, Spring's research has touched upon targeting specific cellular pathways to improve drug cytotoxicity, such as enhancing cisplatin effects in hepatoma cells by targeting the hOGG1 enzyme to mitochondria. His publications also include investigations into the incidence of thyroid carcinoma found incidentally on PET scans and the safety and survival outcomes of novel neoadjuvant immunotherapy regimens for head and neck squamous cell cancer. Spring's scholarly contributions are reflected in an h-index of 18, with 50 publications and 1,263 citations.
Metrics
- h-index: 18
- Publications: 50
- Citations: 1,263
Selected Publications
-
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer (2011)
-
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel‐induced multidrug resistance (2010)
-
Markedly Elevated Serum Calcitonin Concentrations Associated with Initial Presentation But Not the Recurrent Presentation of Medullary Thyroid Carcinoma (2010)
-
<i>In vivo</i> , Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser (2009)
-
Gelatin sponge insertion into tympanostomy tubes: An <i>in‐vitro</i> study to evaluate postoperative obstruction (2009)
-
Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-κB and NF-Y Activation in Oral Carcinoma Cells (2008)
-
Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production (2008)
-
Conductive Interstitial Thermal Therapy (CITT) Device Evaluation in VX2 Rabbit Model (2007)
-
Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells (2007)
-
Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors (2007)
-
Spatially Fractionated Radiation Therapy and Chemotherapy-IMRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (2007)
-
Incidence of Thyroid Carcinoma in Fluorodeoxyglucose Positron Emission Tomography‐Positive Thyroid Incidentalomas (2007)
-
Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer (2007)
-
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells (2007)
-
Conductive interstitial thermal therapy device for surgical margin ablation:<b><i>In vivo</i></b>verification of a theoretical model (2007)
Collaboration Network
Top Collaborators
- Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-κB and NF-Y Activation in Oral Carcinoma Cells
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- 2427
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- 2427
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- 2427
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- 2427
- Conductive interstitial thermal therapy device for surgical margin ablation:<b><i>In vivo</i></b>verification of a theoretical model
- Conductive Interstitial Thermal Therapy (CITT) Device Evaluation in VX2 Rabbit Model
- Spatially Fractionated Radiation Therapy and Chemotherapy-IMRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Conductive interstitial thermal therapy device for surgical margin ablation:<b><i>In vivo</i></b>verification of a theoretical model
- Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production
- Conductive Interstitial Thermal Therapy (CITT) Device Evaluation in VX2 Rabbit Model
- MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel‐induced multidrug resistance
- Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells
- Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer
- Incidence of Thyroid Carcinoma in Fluorodeoxyglucose Positron Emission Tomography‐Positive Thyroid Incidentalomas
- Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer
- Markedly Elevated Serum Calcitonin Concentrations Associated with Initial Presentation But Not the Recurrent Presentation of Medullary Thyroid Carcinoma
- <i>In vivo</i> , Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser
- Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer
- Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2427
- Long Term Results of a Phase II Trial of Hyperfractionated Radiation and Intraarterial Cisplatin (HYPERRADPLAT) on Stage III-IV Head and Neck Cancer With Bulky Primary Tumors
- 2381
- 2417
- Conductive interstitial thermal therapy device for surgical margin ablation:<b><i>In vivo</i></b>verification of a theoretical model
- Conductive Interstitial Thermal Therapy (CITT) Device Evaluation in VX2 Rabbit Model
- Conductive interstitial thermal therapy device for surgical margin ablation:<b><i>In vivo</i></b>verification of a theoretical model
- Conductive Interstitial Thermal Therapy (CITT) Device Evaluation in VX2 Rabbit Model
Similar Researchers
Based on overlapping research topics